Oppenheimer & CO Inc Adaptive Biotechnologies Corp Transaction History

Oppenheimer & CO Inc

  • $6.42 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 11, 2020
SELL
$24.95 - $48.38 $238,422 - $462,319
-9,556 Closed
0 $0
Q1 2020

May 08, 2020
SELL
$16.96 - $34.16 $15,467 - $31,153
-912 Reduced 8.71%
9,556 $265,000
Q4 2019

Feb 07, 2020
BUY
$24.56 - $32.8 $257,094 - $343,350
10,468 New
10,468 $313,000

Others Institutions Holding ADPT

# of Institutions
201
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $670M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email